FineMark National Bank & Trust Has $3.72 Million Stake in Exelon Co. (NASDAQ:EXC)

FineMark National Bank & Trust reduced its stake in Exelon Co. (NASDAQ:EXC) by 4.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 98,921 shares of the company’s stock after selling 4,897 shares during the period. FineMark National Bank & Trust’s holdings in Exelon were worth $3,723,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in Exelon by 2.5% in the fourth quarter. Vanguard Group Inc. now owns 127,335,351 shares of the company’s stock valued at $4,792,903,000 after buying an additional 3,064,673 shares in the last quarter. State Street Corp lifted its stake in shares of Exelon by 3.7% in the 3rd quarter. State Street Corp now owns 60,169,219 shares of the company’s stock valued at $2,439,862,000 after acquiring an additional 2,156,259 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Exelon by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 25,945,791 shares of the company’s stock valued at $1,048,823,000 after acquiring an additional 403,542 shares in the last quarter. FMR LLC grew its position in Exelon by 18.7% during the 3rd quarter. FMR LLC now owns 11,782,549 shares of the company’s stock worth $477,782,000 after acquiring an additional 1,858,502 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Exelon by 1.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,967,343 shares of the company’s stock valued at $363,626,000 after purchasing an additional 160,313 shares during the last quarter. 80.92% of the stock is owned by institutional investors.

Exelon Trading Down 1.9 %

NASDAQ EXC opened at $42.76 on Wednesday. The stock has a market capitalization of $43.17 billion, a P/E ratio of 17.45, a P/E/G ratio of 2.86 and a beta of 0.51. The business has a 50 day simple moving average of $42.19 and a 200 day simple moving average of $40.03. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.87 and a quick ratio of 0.78. Exelon Co. has a one year low of $34.01 and a one year high of $45.20.

Exelon (NASDAQ:EXC) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same quarter in the prior year, the business posted $0.60 earnings per share. Research analysts expect that Exelon Co. will post 2.64 earnings per share for the current year.

Exelon Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a dividend of $0.40 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $1.60 annualized dividend and a dividend yield of 3.74%. This is a positive change from Exelon’s previous quarterly dividend of $0.38. Exelon’s dividend payout ratio is currently 65.31%.

Insider Transactions at Exelon

In related news, EVP Colette D. Honorable sold 1,463 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $40.57, for a total value of $59,353.91. Following the transaction, the executive vice president now directly owns 2,271 shares in the company, valued at $92,134.47. This trade represents a 39.18 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. UBS Group boosted their price target on Exelon from $45.00 to $47.00 and gave the stock a “neutral” rating in a report on Friday, March 21st. BMO Capital Markets restated an “outperform” rating on shares of Exelon in a research report on Tuesday, February 4th. Scotiabank lifted their price target on shares of Exelon from $42.00 to $44.00 and gave the stock a “sector perform” rating in a report on Thursday, February 13th. Barclays increased their price objective on Exelon from $42.00 to $48.00 and gave the company an “overweight” rating in a report on Tuesday, February 25th. Finally, Evercore ISI upgraded Exelon from an “in-line” rating to an “outperform” rating and upped their price target for the company from $43.00 to $44.00 in a research report on Tuesday, January 21st. Four analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $45.13.

About Exelon

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.